Oncology Early Phase / Multiple Disease Site Hematologic Malignancies Early Phase Team Lymphoma NHL DLBCL Treatment Naïve
Categories
Protocols
IIT-HAMADANI-ADCT-LONCA Phase I OPEN TO ACCRUAL
A Multicenter Phase 1, Open-Label Trial of Loncastuximab Tesirine in Combination with DA-EPOCH-R in Patients with Previously Untreated Aggressive B-cell Lymphoid Malignancies